Cairo — Egypt’s stock market entered the new trading week on Sunday, 3 May 2026, building on gains recorded in the 29 April session, when foreign buying helped lift the market to near two-month highs, according to data from the Egyptian Exchange (EGX).
On 29 April, the benchmark EGX30 rose 0.29% to 52,383.13 points, while the EGX35-LV added 0.40%, the EGX70 advanced 0.36%, and the EGX100 gained 0.52%. The EGX33 Shariah index edged down 0.02%. Total market capitalization stood at approximately EGP 3.67tn, EGX data showed.
Investor flows highlighted a shift in positioning. Non-Arab foreign investors were net buyers by EGP 11.34bn, while Egyptian and Arab investors were net sellers, with outflows of EGP 10.8bn and EGP 0.54bn, respectively. The pattern marked a return of foreign support following earlier selling pressure seen through April.
Gains were concentrated in selected sectors. Alexandria New Medical Center rose 20%, while October Pharma and Cleopatra Hospital Company also posted strong advances, reflecting continued interest in healthcare-related stocks. Decliners included Gourmet Egypt.Com Foods, Tycoon Holding for Financial Investments, and Remco for Touristic Villages Construction.
Regionally, sentiment remains sensitive to geopolitical developments. Recent reporting by Reuters in late April indicated that Middle East equity markets have been reacting to developments in US-Iran negotiations, as well as oil price movements and risks to shipping routes through the Strait of Hormuz.
The EGX remains supported near recent highs, with foreign inflows providing intermittent support, while domestic investors continue to take profits. Near-term direction is likely to depend on the durability of external inflows and the evolution of regional risk conditions.
